Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
<h4>Background</h4> <p>Negative symptoms of schizophrenia represent deficiencies in emotional responsiveness, motivation, socialisation, speech and movement. When persistent, they are held to account for much of the poor functional outcomes associated with schizophrenia. There are...
Главные авторы: | Barnes, T, Leeson, V, Paton, C, Costelloe, C, Simon, J, Kiss, N, Osborn, D, Killaspy, H, Craig, T, Lewis, S, Keown, P, Ismail, S, Crawford, M, Baldwin, D, Lewis, G, Geddes, J, Kumar, M, Pathak, R, Taylor, S |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
National Institute for Health Research
2016
|
Схожие документы
-
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
по: Thomas RE Barnes, и др.
Опубликовано: (2016-04-01) -
Long-term antidepressant treatment for negative symptoms in schizophrenia: the actions study
по: Barnes, T, и др.
Опубликовано: (2017) -
Disclosing the potential impact of placebo controls in antidepressant trials
по: Stephanie C. Chen, и др.
Опубликовано: (2015-06-01) -
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
по: Thomas RE Barnes, и др.
Опубликовано: (2017-09-01) -
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
по: Crawford, A, и др.
Опубликовано: (2014)